MG
CME icon

Mather Group’s CME Group CME Stock Holding History

Mather Group’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$567K Sell
2,567
-3
-0.1% -$830 ﹤0.01% 506
2026
Q1 		$759K Buy
2,570
+37
+1% +$11K 0.01% 388
2025
Q4 		$692K Buy
2,533
+320
+14% +$87K 0.01% 344
2025
Q3 		$598K Buy
2,213
+293
+15% +$79.7K 0.01% 371
2025
Q2 		$529K Buy
1,920
+47
+3% +$12.8K 0.01% 380
2025
Q1 		$497K Buy
1,873
+434
+30% +$107K 0.01% 378
2024
Q4 		$334K Buy
1,439
+49
+4% +$11.3K ﹤0.01% 447
2024
Q3 		$307K Sell
1,390
-4,676
-77% -$968K ﹤0.01% 460
2024
Q2 		$1.31M Buy
6,066
+4,025
+197% +$832K 0.02% 230
2024
Q1 		$430K Sell
2,041
-5,128
-72% -$1.08M 0.01% 368
2023
Q4 		$1.51M Sell
7,169
-130
-2% -$27.7K 0.02% 179
2023
Q3 		$1.46M Buy
7,299
+388
+6% +$77.1K 0.03% 169
2023
Q2 		$1.28M Buy
6,911
+145
+2% +$26.8K 0.02% 193
2023
Q1 		$1.3M Buy
+6,766
New +$1.22M 0.02% 185
2022
Q2 		– Sell
-898
Closed -$214K – 395
2022
Q1 		$214K Sell
898
-38
-4% -$8.92K ﹤0.01% 415
2021
Q4 		$214K Buy
+936
New +$206K ﹤0.01% 370

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Mather Group's CME Position: Q2 2026 in Review

Mather Group reduced its CME Group (CME) stake by 0.12% in Q2 2026, selling an estimated $830 and leaving 2,567 shares worth $567K. The position accounts for ﹤0.01% of the portfolio, ranked #506.

Mather Group first reported a position in CME in Q4 2021 and has held it in 16 quarters since. The position peaked at $1.51M in Q4 2023. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Mather Group held 2,567 shares of CME Group worth $567K as of Q2 2026.
  • Mather Group sold 3 CME Group shares in Q2 2026, an estimated $830.
  • CME Group made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #506 holding.
  • Mather Group first reported a position in CME Group in Q4 2021 and has held it in 16 quarters since.
  • Mather Group's CME Group position peaked at $1.51M in Q4 2023.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.